TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 165 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $810,000 | -17.7% | 7,692 | -13.6% | 0.01% | -18.8% |
| Q3 2016 | $984,000 | -55.3% | 8,906 | -41.1% | 0.02% | -55.6% |
| Q2 2016 | $2,203,000 | -8.9% | 15,129 | -10.4% | 0.04% | -10.0% |
| Q1 2016 | $2,419,000 | -15.0% | 16,889 | -8.3% | 0.04% | -11.1% |
| Q4 2015 | $2,846,000 | -2.3% | 18,417 | -9.6% | 0.04% | -2.2% |
| Q3 2015 | $2,913,000 | +20.7% | 20,384 | +21.4% | 0.05% | +39.4% |
| Q2 2015 | $2,413,000 | +36.6% | 16,795 | +34.0% | 0.03% | +37.5% |
| Q1 2015 | $1,767,000 | +106.4% | 12,530 | +117.0% | 0.02% | +118.2% |
| Q4 2014 | $856,000 | +177.0% | 5,774 | +187.8% | 0.01% | +175.0% |
| Q3 2014 | $309,000 | – | 2,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |